New Hope for BTK Inhibitor Intolerant Patients: Pirtobrutinib Shows Promise in B-Cell Malignancies
Pirtobrutinib demonstrates efficacy and tolerability in patients with B-cell cancers who couldn't tolerate other BTKis.
Study compares fosfomycin to ciprofloxacin for preventing infections in leukemia and transplant patients
Study finds no difference in neuropathy between 1-hour and push injection of vincristine in children with cancer